1. Home
  2. CLDX vs NGVT Comparison

CLDX vs NGVT Comparison

Compare CLDX & NGVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

HOLD

Current Price

$23.83

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Ingevity Corporation

NGVT

Ingevity Corporation

HOLD

Current Price

$73.18

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDX
NGVT
Founded
N/A
1964
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
CLDX
NGVT
Price
$23.83
$73.18
Analyst Decision
Buy
Buy
Analyst Count
9
2
Target Price
$41.56
$67.50
AVG Volume (30 Days)
666.2K
296.1K
Earning Date
02-26-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,599,000.00
$1,382,100,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$23.23
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.63
52 Week Low
$14.40
$28.49
52 Week High
$30.50
$77.46

Technical Indicators

Market Signals
Indicator
CLDX
NGVT
Relative Strength Index (RSI) 35.84 69.92
Support Level $22.55 $63.56
Resistance Level $25.60 $77.46
Average True Range (ATR) 1.05 2.72
MACD -0.30 0.16
Stochastic Oscillator 8.05 60.40

Price Performance

Historical Comparison
CLDX
NGVT

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

Share on Social Networks: